{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:10:59Z","timestamp":1787731859756,"version":"build-2784847793"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:00:00Z","timestamp":1610755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:00:00Z","timestamp":1610755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11739-020-02618-3","type":"journal-article","created":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T15:02:28Z","timestamp":1610809348000},"page":"677-686","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical outcomes and costs associated with procalcitonin utilization in hospitalized patients with pneumonia, heart failure, viral respiratory infection, or chronic obstructive pulmonary disease"],"prefix":"10.1007","volume":"16","author":[{"given":"Stacy Aric","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2464-9640","authenticated-orcid":false,"given":"Austin Bernard","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten Leigh","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,16]]},"reference":[{"issue":"9459","key":"2618_CR1","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0140-6736(05)17907-0","volume":"365","author":"H Goossens","year":"2005","unstructured":"Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365(9459):579\u2013587. https:\/\/doi.org\/10.1016\/S0140-6736(05)17907-0","journal-title":"Lancet"},{"issue":"3","key":"2618_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3201\/eid0803.010192","volume":"8","author":"SL Bronzwaer","year":"2002","unstructured":"Bronzwaer SL, Cars O, Buchholz U, Molstad S, Goettsch W, Veldhuijzen IK, Kool JL, Sprenger MJ, Degener JE, European Antimicrobial Resistance Surveillance System (2002) A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 8(3):278\u2013282. https:\/\/doi.org\/10.3201\/eid0803.010192","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"2618_CR3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/jac\/dkt477","volume":"69","author":"C Slimings","year":"2014","unstructured":"Slimings C, Riley TV (2014) Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother 69(4):881\u2013891. https:\/\/doi.org\/10.1093\/jac\/dkt477","journal-title":"J Antimicrob Chemother"},{"issue":"8844","key":"2618_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0140-6736(93)90277-N","volume":"341","author":"M Assicot","year":"1993","unstructured":"Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341(8844):515\u2013518","journal-title":"Lancet"},{"issue":"2","key":"2618_CR5","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1086\/421997","volume":"39","author":"L Simon","year":"2004","unstructured":"Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39(2):206\u2013217. https:\/\/doi.org\/10.1086\/421997","journal-title":"Clin Infect Dis"},{"issue":"9409","key":"2618_CR6","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S0140-6736(04)15591-8","volume":"363","author":"M Christ-Crain","year":"2004","unstructured":"Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Muller B (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363(9409):600\u2013607. https:\/\/doi.org\/10.1016\/S0140-6736(04)15591-8","journal-title":"Lancet"},{"issue":"5","key":"2618_CR7","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1164\/rccm.200708-1238OC","volume":"177","author":"V Nobre","year":"2008","unstructured":"Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J (2008) Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 177(5):498\u2013505. https:\/\/doi.org\/10.1164\/rccm.200708-1238OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"2618_CR8","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1001\/jama.2013.697","volume":"309","author":"P Schuetz","year":"2013","unstructured":"Schuetz P, Briel M, Mueller B (2013) Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections. JAMA 309(7):717\u2013718. https:\/\/doi.org\/10.1001\/jama.2013.697","journal-title":"JAMA"},{"issue":"10","key":"2618_CR9","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/jama.2009.1297","volume":"302","author":"P Schuetz","year":"2009","unstructured":"Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, Neidert S, Fricker T, Blum C, Schild U, Regez K, Schoenenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Mueller B, Pro HSG (2009) Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 302(10):1059\u20131066. https:\/\/doi.org\/10.1001\/jama.2009.1297","journal-title":"JAMA"},{"issue":"12","key":"2618_CR10","doi-asserted-by":"publisher","first-page":"ofy327","DOI":"10.1093\/ofid\/ofy327","volume":"5","author":"J Townsend","year":"2018","unstructured":"Townsend J, Adams V, Galiatsatos P, Pearse D, Pantle H, Masterson M, Kisuule F, Jacob E, Kiruthi C, Ortiz P, Agbanlog A, Jurao R, Stern S, Nayak S, Melgar M, Sama J, Irwin J, Mazidi C, Psoter K, McKenzie R (2018) Procalcitonin-guided antibiotic therapy reduces antibiotic use for lower respiratory tract infections in a United States medical center: results of a clinical trial. Open Forum Infect Dis 5(12):ofy327. https:\/\/doi.org\/10.1093\/ofid\/ofy327","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"2618_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","volume":"18","author":"P Schuetz","year":"2018","unstructured":"Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bucher HC, Annane D, Reinhart K, Falsey AR, Branche A, Damas P, Nijsten M, de Lange DW, Deliberato RO, Oliveira CF, Maravic-Stojkovic V, Verduri A, Beghe B, Cao B, Shehabi Y, Jensen JS, Corti C, van Oers JAH, Beishuizen A, Girbes ARJ, de Jong E, Briel M, Mueller B (2018) Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis 18(1):95\u2013107. https:\/\/doi.org\/10.1016\/S1473-3099(17)30592-3","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"2618_CR12","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1515\/cclm-2018-1181","volume":"57","author":"P Schuetz","year":"2019","unstructured":"Schuetz P, Beishuizen A, Broyles M, Ferrer R, Gavazzi G, Gluck EH, Gonzalez Del Castillo J, Jensen JU, Kanizsai PL, Kwa ALH, Krueger S, Luyt CE, Oppert M, Plebani M, Shlyapnikov SA, Toccafondi G, Townsend J, Welte T, Saeed K (2019) Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clin Chem Lab Med 57(9):1308\u20131318. https:\/\/doi.org\/10.1515\/cclm-2018-1181","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"2618_CR13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.amjmed.2015.06.037","volume":"129","author":"GA Alba","year":"2016","unstructured":"Alba GA, Truong QA, Gaggin HK, Gandhi PU, De Berardinis B, Magrini L, Bajwa EK, Di Somma S, Januzzi JL Jr, Global Research on Acute Conditions Team Network (2016) Diagnostic and prognostic utility of procalcitonin in patients presenting to the emergency department with dyspnea. Am J Med 129(1):96-104.e107. https:\/\/doi.org\/10.1016\/j.amjmed.2015.06.037","journal-title":"Am J Med"},{"key":"2618_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.06.046","author":"RA Balk","year":"2016","unstructured":"Balk RA, Kadri SS, Cao Z, Robinson SB, Lipkin C, Bozzette SA (2016) Effect of procalcitonin testing on healthcare utilization and costs in critically Ill patients in the United States. Chest. https:\/\/doi.org\/10.1016\/j.chest.2016.06.046","journal-title":"Chest"},{"issue":"7","key":"2618_CR15","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","volume":"16","author":"E de Jong","year":"2016","unstructured":"de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, Loef BG, Dormans T, van Melsen GC, Kluiters YC, Kemperman H, van den Elsen MJ, Schouten JA, Streefkerk JO, Krabbe HG, Kieft H, Kluge GH, van Dam VC, van Pelt J, Bormans L, Otten MB, Reidinga AC, Endeman H, Twisk JW, van de Garde EM, de Smet AM, Kesecioglu J, Girbes AR, Nijsten MW, de Lange DW (2016) Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis 16(7):819\u2013827. https:\/\/doi.org\/10.1016\/S1473-3099(16)00053-0","journal-title":"Lancet Infect Dis"},{"key":"2618_CR16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s13054-015-1083-6","volume":"19","author":"J Le Bel","year":"2015","unstructured":"Le Bel J, Hausfater P, Chenevier-Gobeaux C, Blanc FX, Benjoar M, Ficko C, Ray P, Choquet C, Duval X, Claessens YE, ESCAPED Study Group (2015) Diagnostic accuracy of C-reactive protein and procalcitonin in suspected community-acquired pneumonia adults visiting emergency department and having a systematic thoracic CT scan. Crit Care 19:366. https:\/\/doi.org\/10.1186\/s13054-015-1083-6","journal-title":"Crit Care"},{"issue":"7","key":"2618_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, Cooley LA, Dean NC, Fine MJ, Flanders SA, Griffin MR, Metersky ML, Musher DM, Restrepo MI, Whitney CG (2019) Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 200(7):45\u201367. https:\/\/doi.org\/10.1164\/rccm.201908-1581ST","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"2618_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/archinternmed.2012.770","volume":"172","author":"WC Albrich","year":"2012","unstructured":"Albrich WC, Dusemund F, Bucher B, Meyer S, Thomann R, Kuhn F, Bassetti S, Sprenger M, Bachli E, Sigrist T, Schwietert M, Amin D, Hausfater P, Carre E, Gaillat J, Schuetz P, Regez K, Bossart R, Schild U, Mueller B, Pro RST (2012) Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in \u201creal life\u201d: an international, multicenter poststudy survey (ProREAL). Arch Intern Med 172(9):715\u2013722. https:\/\/doi.org\/10.1001\/archinternmed.2012.770","journal-title":"Arch Intern Med"},{"issue":"5","key":"2618_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1469-0691.2009.02709.x","volume":"15","author":"KB Kristoffersen","year":"2009","unstructured":"Kristoffersen KB, Sogaard OS, Wejse C, Black FT, Greve T, Tarp B, Storgaard M, Sodemann M (2009) Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission\u2013a randomized trial. Clin Microb Infect 15(5):481\u2013487. https:\/\/doi.org\/10.1111\/j.1469-0691.2009.02709.x","journal-title":"Clin Microb Infect"},{"issue":"6","key":"2618_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation modification of diet in renal disease study group. Ann Intern Med 130(6):461\u2013470","journal-title":"Ann Intern Med"},{"issue":"10","key":"2618_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/qjmed\/94.10.521","volume":"94","author":"CP Subbe","year":"2001","unstructured":"Subbe CP, Kruger M, Rutherford P, Gemmel L (2001) Validation of a modified Early Warning Score in medical admissions. QJM 94(10):521\u2013526","journal-title":"QJM"},{"issue":"6","key":"2618_CR22","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1378\/chest.12-1605","volume":"143","author":"MM Churpek","year":"2013","unstructured":"Churpek MM, Yuen TC, Edelson DP (2013) Risk stratification of hospitalized patients on the wards. Chest 143(6):1758\u20131765. https:\/\/doi.org\/10.1378\/chest.12-1605","journal-title":"Chest"},{"issue":"5","key":"2618_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"issue":"10","key":"2618_CR24","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2016.12226","volume":"316","author":"VS Lee","year":"2016","unstructured":"Lee VS, Kawamoto K, Hess R, Park C, Young J, Hunter C, Johnson S, Gulbransen S, Pelt CE, Horton DJ, Graves KK, Greene TH, Anzai Y, Pendleton RC (2016) Implementation of a value-driven outcomes program to identify high variability in clinical costs and outcomes and association with reduced cost and improved quality. JAMA 316(10):1061\u20131072. https:\/\/doi.org\/10.1001\/jama.2016.12226","journal-title":"JAMA"},{"issue":"2","key":"2618_CR25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1177\/1536867X1201200209","volume":"12","author":"R Williams","year":"2012","unstructured":"Williams R (2012) Using the margins command to estimate and interpret adjusted predictions and marginal effects. Stata J 12(2):308\u2013331","journal-title":"Stata J"},{"key":"2618_CR26","unstructured":"Prevention CfDCa (2013) Antibiotic resistance threats in the United States, 2013"},{"issue":"17","key":"2618_CR27","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1001\/jama.2016.4151","volume":"315","author":"KE Fleming-Dutra","year":"2016","unstructured":"Fleming-Dutra KE, Hersh AL, Shapiro DJ, Bartoces M, Enns EA, File TM Jr, Finkelstein JA, Gerber JS, Hyun DY, Linder JA, Lynfield R, Margolis DJ, May LS, Merenstein D, Metlay JP, Newland JG, Piccirillo JF, Roberts RM, Sanchez GV, Suda KJ, Thomas A, Woo TM, Zetts RM, Hicks LA (2016) Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010\u20132011. JAMA 315(17):1864\u20131873. https:\/\/doi.org\/10.1001\/jama.2016.4151","journal-title":"JAMA"},{"issue":"1","key":"2618_CR28","doi-asserted-by":"publisher","first-page":"ofw249","DOI":"10.1093\/ofid\/ofw249","volume":"4","author":"C Rhee","year":"2017","unstructured":"Rhee C (2017) Using procalcitonin to guide antibiotic therapy. Open Forum Infect Dis 4(1):ofw249. https:\/\/doi.org\/10.1093\/ofid\/ofw249","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"2618_CR29","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1515\/cclm-2014-1015","volume":"53","author":"P Schuetz","year":"2015","unstructured":"Schuetz P, Balk R, Briel M, Kutz A, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Luyt CE, Chastre J, Tubach F, Mueller B, Lacey MJ, Ohsfeldt RL, Scheibling CM, Schneider JE (2015) Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective. Clin Chem Lab Med 53(4):583\u2013592. https:\/\/doi.org\/10.1515\/cclm-2014-1015","journal-title":"Clin Chem Lab Med"},{"key":"2618_CR30","doi-asserted-by":"publisher","first-page":"CD007498","DOI":"10.1002\/14651858.CD007498.pub3","volume":"10","author":"P Schuetz","year":"2017","unstructured":"Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bucher HC, Bhatnagar N, Annane D, Reinhart K, Branche A, Damas P, Nijsten M, de Lange DW, Deliberato RO, Lima SS, Maravic-Stojkovic V, Verduri A, Cao B, Shehabi Y, Beishuizen A, Jensen JS, Corti C, Van Oers JA, Falsey AR, de Jong E, Oliveira CF, Beghe B, Briel M, Mueller B (2017) Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev 10:CD007498. https:\/\/doi.org\/10.1002\/14651858.CD007498.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2618_CR31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1164\/rccm.200512-1922OC","volume":"174","author":"M Christ-Crain","year":"2006","unstructured":"Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR, Zimmerli W, Harbarth S, Tamm M, Muller B (2006) Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 174(1):84\u201393. https:\/\/doi.org\/10.1164\/rccm.200512-1922OC","journal-title":"Am J Respir Crit Care Med"},{"key":"2618_CR32","unstructured":"Weiss AJ, Elixhauser A (2014) Overview of hospital stays in the United States, 2012: Statistical Brief #180. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD)"},{"issue":"1","key":"2618_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.chest.2016.06.046","volume":"151","author":"RA Balk","year":"2017","unstructured":"Balk RA, Kadri SS, Cao Z, Robinson SB, Lipkin C, Bozzette SA (2017) Effect of procalcitonin testing on health-care utilization and costs in critically Ill patients in the United States. Chest 151(1):23\u201333. https:\/\/doi.org\/10.1016\/j.chest.2016.06.046","journal-title":"Chest"},{"issue":"9","key":"2618_CR34","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1056\/NEJMp058011","volume":"352","author":"AS Kesselheim","year":"2005","unstructured":"Kesselheim AS, Brennan TA (2005) Overbilling vs. downcoding\u2014the battle between physicians and insurers. N Engl J Med 352(9):855\u2013857. https:\/\/doi.org\/10.1056\/NEJMp058011","journal-title":"N Engl J Med"},{"issue":"14","key":"2618_CR35","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.283.14.1858","volume":"283","author":"MK Wynia","year":"2000","unstructured":"Wynia MK, Cummins DS, VanGeest JB, Wilson IB (2000) Physician manipulation of reimbursement rules for patients: between a rock and a hard place. JAMA 283(14):1858\u20131865. https:\/\/doi.org\/10.1001\/jama.283.14.1858","journal-title":"JAMA"},{"key":"2618_CR36","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.thromres.2017.10.004","volume":"159","author":"T Delate","year":"2017","unstructured":"Delate T, Jones AE, Clark NP, Witt DM (2017) Assessment of the coding accuracy of warfarin-related bleeding events. Thromb Res 159:86\u201390. https:\/\/doi.org\/10.1016\/j.thromres.2017.10.004","journal-title":"Thromb Res"},{"issue":"1","key":"2618_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.thromres.2010.03.009","volume":"126","author":"RH White","year":"2010","unstructured":"White RH, Garcia M, Sadeghi B, Tancredi DJ, Zrelak P, Cuny J, Sama P, Gammon H, Schmaltz S, Romano PS (2010) Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States. Thromb Res 126(1):61\u201367. https:\/\/doi.org\/10.1016\/j.thromres.2010.03.009","journal-title":"Thromb Res"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-020-02618-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-020-02618-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-020-02618-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T15:27:01Z","timestamp":1618500421000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-020-02618-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,16]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2618"],"URL":"https:\/\/doi.org\/10.1007\/s11739-020-02618-3","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,16]]},"assertion":[{"value":"30 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approved by University of Utah Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable, retrospective cohort study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable, retrospective cohort study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}